Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06966388 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Nov 30, 2026 to Nov 30, 2027v5
  2. Eligibility criteria expanded, about 45 wordsv4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Aug 31, 2025 to Aug 13, 2025
    • Site details revised
    v3
  4. Re-verified, no change to tracked fieldsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This pilot study will evaluate the feasibility of at least twice daily use of azelaic acid in breast cancer patients undergoing radiation treatment.
Trial Details
NCT Number NCT06966388
Lead Sponsor Virginia Commonwealth University
Conditions
(from sponsor)		 Breast Cancer
Related terms Breast Neoplasms
Enrollment 33 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov